Top 350+ Solved Biopharmaceutics and Pharmacokinetics MCQ Questions Answer
Q. Bioavailability is defined as…..
a. Rate of drug absorption
b. Rate of drug distribution
c. Rate of drug elimination
d. Rate and extent of absorption
Q. The rate of drug bioavailability is most rapid when the drug is formulated as a…..
a. controlled released product
b. hard gelatin capsule
c. tablet
d. solution
Q. The drug concentration between MEC and MSC represents the….
a. Therapeutic Index
b. Therapeutic range
c. Therapeutic outcome
d. Therapeutic ratio
Q. Dissolution test apparatus I as per IP is…..
a. Paddle
b. Basket
c. Rotating basket
d. Rotating paddle
Q. Non-invasive measurement of drug concentration includes ……….sampling.
a. hair
b. urine
c. saliva
d. All of the above
Q. Ex-vivo models refer to…….
a. in the body
b. in the computer
c. outside the body
d. none of the above
Q. USP dissolution test apparatus type-II is also called as…..
a. Hansen paddle type
b. paddle over disc
c. Rotating basket type
d. none of the above
Q. Bioavailability of drug from topical administration is affected by…..
a. Skin condition
b. Topical vehicle
c. Application condition
d. all of the above
Q. What is bioavailability?
a. The time of absorption of the drug from its dosage form
b. The rate of absorption of the unchanged drug from its dosage form
c. The time of absorption of the unchanged drug from its dosage form
d. The rate of absorption of the drug from its dosage form
Q. What is the equation of bioavailable fraction?
a. 1/Bioavailable dose
b. 1/Administered dose
c. Bioavailable dose/Administered dose
d. Administered dose/Bioavailable dose
Q. Which of the following is not an objective of bioavailability studies?
a. Primary stages of development of suitable dosage form for new drug
b. Determination of the influence of excipients, patient-related factors, etc
c. Development of new formulations of the existing drugs
d. Control the quantity of the drug to be administered
Q. Multiple dose study is better since we can understand the peak, valley, drug blood levels, etc.
a. True
b. False
c. none
d. all
Q. Which of the following is the pharmacodynamics method of studying bioavailability?
a. Acute pharmacologic response
b. Plasma-level time studies
c. Urinary excretion studies
d. Stool excretion studies